Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Dynamic Kinetic Resolution of Alkenyl Cyanohydrins Derived from α,β-Unsaturated Aldehydes: Stereoselective Synthesis of E-Tetrasubstituted Olefins.

Majhi J, Turnbull BWH, Ryu H, Park J, Baik MH, Evans PA.

J Am Chem Soc. 2019 Jul 22. doi: 10.1021/jacs.9b04384. [Epub ahead of print]

PMID:
31180679
2.

Enantioselective Rhodium-Catalyzed Allylic Alkylation of β,γ-Unsaturated α-Amino Nitriles: Synthetic Homoenolate Equivalents.

Wright TB, Turnbull BWH, Evans PA.

Angew Chem Int Ed Engl. 2019 Apr 7. doi: 10.1002/anie.201900442. [Epub ahead of print]

PMID:
30957357
3.

Asymmetric Rhodium-Catalyzed Allylic Substitution Reactions: Discovery, Development and Applications to Target-Directed Synthesis.

Turnbull BWH, Evans PA.

J Org Chem. 2018 Oct 5;83(19):11463-11479. doi: 10.1021/acs.joc.8b00583. Epub 2018 Sep 5.

PMID:
30183287
4.

Enantioselective Ruthenium-Catalyzed Benzocyclobutenone-Ketol Cycloaddition: Merging C-C Bond Activation and Transfer Hydrogenative Coupling for Type II Polyketide Construction.

Ambler BR, Turnbull BWH, Suravarapu SR, Uteuliyev MM, Huynh NO, Krische MJ.

J Am Chem Soc. 2018 Jul 25;140(29):9091-9094. doi: 10.1021/jacs.8b05724. Epub 2018 Jul 11.

PMID:
29992811
5.

Thermal Hetero-Diels-Alder Reaction of Benzocyclobutenones with Isatins To Form 2-Oxindole Spirolactones.

Wurm T, Turnbull BWH, Ambler BR, Krische MJ.

J Org Chem. 2017 Dec 15;82(24):13751-13755. doi: 10.1021/acs.joc.7b02769. Epub 2017 Nov 22.

6.

Ruthenium(0)-Catalyzed Cycloaddition of 1,2-Diols, Ketols, or Diones via Alcohol-Mediated Hydrogen Transfer.

Sato H, Turnbull BWH, Fukaya K, Krische MJ.

Angew Chem Int Ed Engl. 2018 Mar 12;57(12):3012-3021. doi: 10.1002/anie.201709916. Epub 2018 Feb 6. Review.

7.

Ruthenium-catalyzed insertion of adjacent diol carbon atoms into C-C bonds: Entry to type II polyketides.

Bender M, Turnbull BWH, Ambler BR, Krische MJ.

Science. 2017 Aug 25;357(6353):779-781. doi: 10.1126/science.aao0453.

8.

Regio- and stereospecific rhodium-catalyzed allylic alkylation with an acyl anion equivalent: an approach to acyclic α-ternary β,γ-unsaturated aryl ketones.

Turnbull BWH, Chae J, Oliver S, Evans PA.

Chem Sci. 2017 May 1;8(5):4001-4005. doi: 10.1039/c6sc05705e. Epub 2017 Mar 31.

9.

Adaptive designs from a Data Safety Monitoring Board perspective: Some controversies and some case studies.

Turnbull BW.

Clin Trials. 2017 Oct;14(5):462-469. doi: 10.1177/1740774516689261. Epub 2017 Feb 9.

PMID:
28178849
10.

Stereospecific Rhodium-Catalyzed Allylic Substitution with Alkenyl Cyanohydrin Pronucleophiles: Construction of Acyclic Quaternary Substituted α,β-Unsaturated Ketones.

Turnbull BW, Oliver S, Evans PA.

J Am Chem Soc. 2015 Dec 16;137(49):15374-7. doi: 10.1021/jacs.5b10270. Epub 2015 Nov 25.

PMID:
26606387
11.

Adaptive sample size modification in clinical trials: start small then ask for more?

Jennison C, Turnbull BW.

Stat Med. 2015 Dec 20;34(29):3793-810. doi: 10.1002/sim.6575. Epub 2015 Jul 14.

PMID:
26172385
12.

Enantioselective rhodium-catalyzed allylic substitution with a nitrile anion: construction of acyclic quaternary carbon stereogenic centers.

Turnbull BW, Evans PA.

J Am Chem Soc. 2015 May 20;137(19):6156-9. doi: 10.1021/jacs.5b02810. Epub 2015 May 5.

PMID:
25941763
13.

Group sequential enrichment design incorporating subgroup selection.

Magnusson BP, Turnbull BW.

Stat Med. 2013 Jul 20;32(16):2695-714. doi: 10.1002/sim.5738. Epub 2013 Jan 13.

PMID:
23315698
14.

Bayesian analysis of longitudinal Johne's disease diagnostic data without a gold standard test.

Wang C, Turnbull BW, Nielsen SS, Gröhn YT.

J Dairy Sci. 2011 May;94(5):2320-8. doi: 10.3168/jds.2010-3675.

15.

Adaptive seamless designs: selection and prospective testing of hypotheses.

Jennison C, Turnbull BW.

J Biopharm Stat. 2007;17(6):1135-61. Review.

PMID:
18027222
16.
17.
18.

On the multivariate probit model for exchangeable binary data with covariates.

Stefanescu C, Turnbull BW.

Biom J. 2005 Apr;47(2):206-18.

PMID:
16389918
19.

Efficient group sequential designs when there are several effect sizes under consideration.

Jennison C, Turnbull BW.

Stat Med. 2006 Mar 30;25(6):917-32.

PMID:
16220524
20.

Meta-analyses and adaptive group sequential designs in the clinical development process.

Jennison C, Turnbull BW.

J Biopharm Stat. 2005;15(4):537-58.

PMID:
16022162
21.

Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.

Duffield-Lillico AJ, Slate EH, Reid ME, Turnbull BW, Wilkins PA, Combs GF Jr, Park HK, Gross EG, Graham GF, Stratton MS, Marshall JR, Clark LC; Nutritional Prevention of Cancer Study Group.

J Natl Cancer Inst. 2003 Oct 1;95(19):1477-81.

PMID:
14519754
22.

Likelihood inference for exchangeable binary data with varying cluster sizes.

Stefanescu C, Turnbull BW.

Biometrics. 2003 Mar;59(1):18-24.

PMID:
12762437
23.

Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.

Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, Marshall JR, Clark LC; Nutritional Prevention of Cancer Study Group.

BJU Int. 2003 May;91(7):608-12.

24.

Mid-course sample size modification in clinical trials based on the observed treatment effect.

Jennison C, Turnbull BW.

Stat Med. 2003 Mar 30;22(6):971-93.

PMID:
12627413
25.

Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial.

Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR.

Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1285-91.

26.

Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.

Duffield-Lillico AJ, Reid ME, Turnbull BW, Combs GF Jr, Slate EH, Fischbach LA, Marshall JR, Clark LC.

Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):630-9.

27.

Discovering subpopulation structure with latent class mixed models.

McCulloch CE, Lin H, Slate EH, Turnbull BW.

Stat Med. 2002 Feb 15;21(3):417-29.

PMID:
11813228
28.

An analysis of cancer prevention by selenium.

Combs GF Jr, Clark LC, Turnbull BW.

Biofactors. 2001;14(1-4):153-9. Review.

PMID:
11568452
29.

A latent class mixed model for analysing biomarker trajectories with irregularly scheduled observations.

Lin H, McCulloch CE, Turnbull BW, Slate EH, Clark LC.

Stat Med. 2000 May 30;19(10):1303-18.

PMID:
10814979
30.

Statistical models for longitudinal biomarkers of disease onset.

Slate EH, Turnbull BW.

Stat Med. 2000 Feb 29;19(4):617-37.

PMID:
10694740
31.

Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.

Clark LC, Dalkin B, Krongrad A, Combs GF Jr, Turnbull BW, Slate EH, Witherington R, Herlong JH, Janosko E, Carpenter D, Borosso C, Falk S, Rounder J.

Br J Urol. 1998 May;81(5):730-4.

PMID:
9634050
32.

Reduction of cancer mortality and incidence by selenium supplementation.

Combs GF Jr, Clark LC, Turnbull BW.

Med Klin (Munich). 1997 Sep 15;92 Suppl 3:42-5.

PMID:
9342915
33.

Reduction of cancer risk with an oral supplement of selenium.

Combs GF Jr, Clark LC, Turnbull BW.

Biomed Environ Sci. 1997 Sep;10(2-3):227-34.

PMID:
9315315
34.

Regression models for recurrent event data: parametric random effects models with measurement error.

Turnbull BW, Jiang W, Clark LC.

Stat Med. 1997 Apr 30;16(8):853-64.

PMID:
9160484
35.

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR.

JAMA. 1996 Dec 25;276(24):1957-63. Erratum in: JAMA 1997 May 21;277(19):1520.

PMID:
8971064
36.

A computer program for sample size and power calculations in the design of multi-arm and factorial clinical trials with survival time endpoints.

Natarajan R, Turnbull BW, Slate EH, Clark LC.

Comput Methods Programs Biomed. 1996 Mar;49(2):137-47.

PMID:
8735021
37.

Detection and assessment of clusters of disease: an application to nuclear power plant facilities and childhood leukaemia in Sweden.

Waller LA, Turnbull BW, Gustafsson G, Hjalmars U, Andersson B.

Stat Med. 1995 Jan 15;14(1):3-16.

PMID:
7701156
38.

A computer program for the statistical analysis of repeated event data using a mixed effects regression model.

Natarajan R, Turnbull BW, Slate EH, Wells MT, Clark LC, Abu-Libdeh H.

Comput Methods Programs Biomed. 1994 Apr;42(4):283-94.

PMID:
7924275
39.

The effects of scale on tests for disease clustering.

Waller LA, Turnbull BW.

Stat Med. 1993 Oct;12(19-20):1869-84.

PMID:
8272667
40.
41.
42.

Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps.

Clark LC, Hixson LJ, Combs GF Jr, Reid ME, Turnbull BW, Sampliner RE.

Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb;2(1):41-6.

43.

Optimal checking procedures for monitoring laboratory analyses.

McShane LM, Turnbull BW.

Stat Med. 1992 Jul;11(10):1343-57.

PMID:
1518995
44.

Reporting the accuracy of biochemical measurements for epidemiologic and nutrition studies.

McShane LM, Clark LC, Combs GF Jr, Turnbull BW.

Am J Clin Nutr. 1991 Jun;53(6):1354-60.

PMID:
2035462
45.

Analysis of multi-type recurrent events in longitudinal studies; application to a skin cancer prevention trial.

Abu-Libdeh H, Turnbull BW, Clark LC.

Biometrics. 1990 Dec;46(4):1017-34.

PMID:
2085623
46.

Monitoring for clusters of disease: application to leukemia incidence in upstate New York.

Turnbull BW, Iwano EJ, Burnett WS, Howe HL, Clark LC.

Am J Epidemiol. 1990 Jul;132(1 Suppl):S136-43.

PMID:
2356825
47.

Detection of associations between diseases in animal carcinogenicity experiments.

Mitchell TJ, Turnbull BW.

Biometrics. 1990 Jun;46(2):359-74.

PMID:
2364126
48.
49.

Repeated confidence intervals for group sequential clinical trials.

Jennison C, Turnbull BW.

Control Clin Trials. 1984 Mar;5(1):33-45.

PMID:
6713906
50.

Effect of BCG immunotherapy on N-nitroso-N-methylurea-induced carcinogenesis of guinea pig colon.

Cockerell GL, O'Donnell RW, Kriedemann WL, Amato DA, Turnbull BW.

J Natl Cancer Inst. 1984 Mar;72(3):621-30.

PMID:
6366320

Supplemental Content

Loading ...
Support Center